Showing posts with label Shares. Show all posts
Showing posts with label Shares. Show all posts

Friday, 25 September 2015

Global Solar Cell Industry Key Trends, Size, Growth, Shares And Forecast 2015 Market Research Report

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Solar Cell market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.


Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Solar Cell industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 235 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Browse All Reports in Power Category @ http://www.researchmoz.us/power-market-reports-26.html

Table of Contents

1 Industry Overview

1.1 Definition and Specifications of Solar Cell

1.2 Classification of Solar Cell

1.3 Applications of Solar Cell

1.4 Industry Chain Structure of Solar Cell

1.5 Industry Regional Overview of Solar Cell

1.6 Industry Policy Analysis of Solar Cell

1.7 Industry News Analysis of Solar Cell

2 Manufacturing Cost Structure Analysis of Solar Cell

2.1 Raw Material Suppliers and Price Analysis of Solar Cell

2.2 Equipment Suppliers and Price Analysis of Solar Cell

2.3 Labor Cost Analysis of Solar Cell

2.4 Other Costs Analysis of Solar Cell

2.5 Manufacturing Cost Structure Analysis of Solar Cell

2.6 Manufacturing Process Analysis of Solar Cell

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014

3.2 Manufacturing Plants Distribution of Global Key Solar Cell Manufacturers in 2014

3.3 R&D Status and Technology Source of Global Solar Cell Key Manufacturers in 2014

3.4 Raw Materials Sources Analysis of Global Solar Cell Key Manufacturers in 2014

4 Production Analysis of Solar Cell by Regions, Technology, and Applications

4.1 Global Production of Solar Cell by Regions (US, EU, China, Japan, etc.) 2010–2015

4.2 Global Production of Solar Cell by Technology 2010–2015

4.3 Global Production of Solar Cell by Applications 2010–2015

4.4 Price Analysis of Global Solar Cell Key Manufacturers in 2015

4.5 US Capacity, Production, Price, Cost and Revenue of Solar Cell 2010–2015

4.6 EU Capacity, Production, Price, Cost and Revenue of Solar Cell 2010–2015

4.7 Japan Capacity, Production, Price, Cost and Revenue of Solar Cell 2010–2015

4.8 China Capacity, Production, Price, Cost and Revenue of Solar Cell 2010–2015

4.9 US Supply, Import, Export and Consumption of Solar Cell 2010–2015

4.10 EU Supply, Import, Export and Consumption of Solar Cell 2010–2015

4.11 Japan Supply, Import, Export and Consumption of Solar Cell 2010–2015

4.12 China Supply, Import, Export and Consumption of Solar Cell 2010–2015

For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.html

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted by at No comments:
Labels: , , ,

Wednesday, 2 September 2015

China Telemedicine and Online Healthcare Industry, 2015 Key Trends, Size, Growth, Shares And Forecast Research Report

Product Synopsis

Due to the severely imbalanced medical resources,telemedicine and online healthcare have huge development penitential in China. The rapid development of medical informatization and wearable devices have and will continue to boost the bright prospect of telemedicine and online healthcare in China.

By the end of 2014, 50% of provincial level hospitals and 42% of primary hospitals has built up telemedicine centers in China respectively. Viewing from specific businesses, expert consultation is the most developed business, along with medical image consultation, education & training and pathology consultation.


Approximate RMB 16.36 billion been invested on telemedicine in China in 2014, among which, PACS System, Regional Medical Information Platform and HIS System ranked the top 3 segments with investment amount of RMB 3.74, 3.06 and 1.84 billion respectively.

Policies have largely limited the development of online healthcare in China. In August 2014, NHFPC of China released the ‘Advanced on the Telemedicine Services among Medical Institutions’, which stipulated that non-medical institutions cannot develop telemedicine, only health consultation is permitted.


Even so, the market size of online healthcare industry in China still reached RMB 10.88 billion in 2014, where transaction revenue accounts for more than 90% of the market share along with the decreased advertisement revenue in recent 5 years. It’s worth noting that smart devices accounts for 3.1% of the total transaction revenue in China in 2014. Currently the smart devices and services have not fully connected, this segment remains in the incubation period.

The huge demand for telemedicine has already attracted some leading enterprises to invest in Chinese telemedicine market. The largest radiology service company in the US, vRad, signed a strategic cooperation agreement with E-TECHCO in April 2014. Both sides will provide tele radiology services for patients in the greater China region. The largest telemedicine consultation and service institution, WorldCare, has set up the ‘China WorldCare (Beijing) Hospital Management Co., Ltd. Meanwhile, World Care has reached cooperation intentions with many regional goverments such as Nanjing. Mayo Clinic, built up a joint venture with HILLHOUSE Capital in January 2015.


About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact: 

Mr. Nachiket, 
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
State Tower 
90 State Street, Suite 700 
Albany, NY 12207 
United States 
Posted by at No comments:
Labels: , , , ,

Biliary Cirrhosis - Pipeline Review, H2 2015 : Global Industry Growth, Research, Analysis, Shares and Forecast

Product Synopsis

Biliary Cirrhosis - Pipeline Review, H2 2015

Summary

Global Markets Directs, Biliary Cirrhosis - Pipeline Review, H2 2015, provides an overview of the Biliary Cirrhosiss therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Biliary Cirrhosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Biliary Cirrhosis and special features on late-stage and discontinued projects.


Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Biliary Cirrhosis
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved in the therapeutics development for Biliary Cirrhosis and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects 
- A review of the Biliary Cirrhosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Biliary Cirrhosis pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products


Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Biliary Cirrhosis
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Biliary Cirrhosis pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948

Posted by at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)